The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment pattern and clinical outcomes among patients with metastatic renal cell (mRCC) carcinoma post PD-1/PD-L1 immuno-oncology (IO) therapies.
 
Neil Shah
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis; HiberCell (Inst)
Travel, Accommodations, Expenses - Merck
 
Rahul Ravilla
Honoraria - Astellas Pharma; Exelixis; Johnson & Johnson/Janssen; Merck
Consulting or Advisory Role - Pfizer/Astellas
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Exelixis; Johnson & Johnson/Janssen; Merck; Pfizer/Astellas
 
Andrew Osterland
Employment - McKesson
 
Karen Todoroff
No Relationships to Disclose
 
Ching-Yu Wang
Employment - Merck
 
Pratik Rane
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Hakim Saal
Employment - Eisai
 
Ding Wang
Employment - Merck
Stock and Other Ownership Interests - Merck; Merck
 
Robert Motzer
Consulting or Advisory Role - Aveo; EMD Serono; Exelixis; Incyte; Merck; Takeda
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb